EMD Serono

234 articles about EMD Serono

• Opexa Therapeutics Amends Agreement With Merck Serono And Receives Additional $3 Million Payment To Support Ongoing Development Of Tcelna For Multiple Sclerosis

  3/9/2015

• Merck Serono, Institute Of Cancer Research, Wellcome Trust To Co-Develop Cancer Drugs

  10/7/2014

• Lupin Ltd., Merck Serono Forge Emerging Markets Pact; Deal Could Add Up To 20 Drugs To Merck's Portfolio

  9/16/2014

• Lupin Ltd. May Sign $1.5 Billion Deal With Merck Serono; Lupin Stock Hits A New High

  9/15/2014

• Merck Serono Breaks Ground On $105 Million Plant; Will Be The Company's Second Largest Manufacturing Facility Worldwide

  8/28/2014

• Kadimastem To Collaborate With Merck Serono To Advance Combined Efforts In Neurodegenerative Disease Area

  8/4/2014

• MorphoSys AG And Merck Serono Enter Strategic Immuno-Oncology Collaboration

  6/12/2014

• Merck Serono Announces FDA Win For Auxogyn, Inc.'s Early Embryo Viability Assessment (Eeva®) System

  6/11/2014

• Merck Serono's President & CEO Belén Garijo Has Been Appointed To Board Of Directors Of L'Oréal

  4/18/2014

• Auxogyn, Inc., Merck Serono Strike Eeva Test Pact

  4/3/2014

• Merck's Consumer Health Division Breaks $1 Billion Barrier By Incorporating Brands From Merck Serono

  3/6/2014

• Merck Serono Has Named Dr. John Orloff As Head Of Global Clinical Development

  2/11/2014

• Week in Review: BeiGene Co.,Ltd Out-Licenses Novel Cancer Drug to Merck Serono

  11/18/2013

• BeiGene Co.,Ltd, Merck Serono Add $232 Million+ R&D Deal To Growing Cancer Partnership

  11/13/2013

• Merck Serono and Kadimastem Sign Memorandum of Understanding (MOU) on Drug Screening and Discovery for Neurodegenerative Diseases

  11/4/2013

• Lead Discovery Center Announces Five-Year Strategic Partnership With Merck Serono

  10/31/2013

• Merck Serono Takes a Chance and Funds Four Academia MS Projects

  10/9/2013

• Merck Serono's Erbitux Significantly Extends Survival by 7.5 Months in mCRC RAS Wild-Type Patients When Compared With Bevacizumab: New Analysis of FIRE-3 AIO Study

  9/30/2013

• Merck Serono to Breathe New Life Into Oncothyreon Inc.'s Failed Lung Cancer Drug

  9/26/2013

• Ablynx and Merck Serono Further Strengthen Their Collaboration on Co-Discovery and Co-Development of Nanobodies

  9/26/2013